Compare PB & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PB | BLCO |
|---|---|---|
| Founded | 1983 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.9B |
| IPO Year | 1998 | 2022 |
| Metric | PB | BLCO |
|---|---|---|
| Price | $67.80 | $16.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | ★ $79.00 | $18.45 |
| AVG Volume (30 Days) | ★ 821.0K | 418.4K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.49% | N/A |
| EPS Growth | ★ 13.27 | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | N/A | ★ $5,101,000,000.00 |
| Revenue This Year | $41.06 | $8.65 |
| Revenue Next Year | $17.07 | $5.59 |
| P/E Ratio | $59.14 | ★ N/A |
| Revenue Growth | N/A | ★ 6.47 |
| 52 Week Low | $61.07 | $10.99 |
| 52 Week High | $77.20 | $18.92 |
| Indicator | PB | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 49.51 |
| Support Level | $64.34 | $14.39 |
| Resistance Level | $70.52 | $16.61 |
| Average True Range (ATR) | 1.61 | 0.47 |
| MACD | -0.18 | 0.03 |
| Stochastic Oscillator | 23.72 | 76.09 |
Prosperity Bancshares Inc provides retail and commercial banking services to individuals and small to midsize businesses. It provides a wide array of financial products and services to businesses and consumers throughout Texas and Oklahoma. The group provides Personal, Business, Mortgage, and Banking Services.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.